Optase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Optase
Generic name
GLYCERIN
Manufacturer
Scope Health Inc
Product type
HUMAN OTC DRUG
SPL set ID
86c14327-ffc7-806e-e053-2991aa0aaf92
SPL ID
5eb21697-e92b-9e18-e063-6394a90a09bb
Version
12
Effective date
2026-10-25
Source export date
2026-11-13
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/2aa9706206c534e56285cf80077b2cca2320f0a236e2aa30e80d064749f7c888/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 16:02:21
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning • For external use only. To avoid contamination, do not touch tip of container to any surface. Replace cap after using. • If solution changes color or becomes cloudy, do not use. Stop use and ask doctor if • You feel eye pain. • Changes in vision occur. • Redness or irritation of the eye lasts. • Condition worsens or lasts more than 72 hours

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.